Trials / Completed
CompletedNCT03582449
Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this non-interventional, observational study which is conducted in Mexico is to evaluate the safety profile of elaprase (idulsurfase) in participants with hunter syndrome (mucopolysaccharydosis II) being treated with elaprase.
Conditions
Timeline
- Start date
- 2018-01-19
- Primary completion
- 2020-05-10
- Completion
- 2020-05-10
- First posted
- 2018-07-11
- Last updated
- 2023-09-15
Locations
6 sites across 1 country: Mexico
Source: ClinicalTrials.gov record NCT03582449. Inclusion in this directory is not an endorsement.